OPKO Health, Inc. Increase (Decrease) in Other Operating Assets
OPKO Health, Inc. (OPK) reported Increase (Decrease) in Other Operating Assets of $298.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-28
- OPKO Health, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $172.00K.
- OPKO Health, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $126.00K, a 86.97% decline year-over-year.
- OPKO Health, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$121.00K, a 137.00% decline year-over-year.
- OPKO Health, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$412.00K.
- OPKO Health, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$23.00K.
- OPKO Health, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$237.00K, a 182.29% decline from fiscal 2023.
- OPKO Health, Inc. increase (decrease) in other operating assets for fiscal 2023 was $288.00K.
- OPKO Health, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$1.94M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $172.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $298.00K 10-Q/A · filed 2026-08-28 | $177.00K derived: sum of 3 quarters · filed 2026-08-28 | -$235.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $126.00K 10-Q/A · filed 2026-08-28 | $5.00K derived: sum of 2 quarters · filed 2026-08-28 | -$407.00K derived: sum of 3 quarters · filed 2026-08-28 | -$864.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$533.00K derived: sum of 2 quarters · filed 2026-02-26 | -$990.00K derived: sum of 3 quarters · filed 2026-08-28 | -$23.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$412.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | -$869.00K derived: sum of 2 quarters · filed 2026-08-28 | $98.00K 10-Q · filed 2025-10-29 | $425.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | -$457.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $510.00K 10-Q/A · filed 2026-08-28 | $837.00K derived: sum of 3 quarters · filed 2026-08-28 | $157.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $967.00K 10-Q/A · filed 2026-08-28 | $1.29M derived: sum of 2 quarters · filed 2026-08-28 | $614.00K derived: sum of 3 quarters · filed 2026-08-28 | $737.00K derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$353.00K derived: sum of 2 quarters · filed 2026-02-26 | -$230.00K derived: sum of 3 quarters · filed 2026-02-26 | -$237.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$680.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$557.00K derived: sum of 2 quarters · filed 2025-10-29 | -$564.00K 10-Q · filed 2025-10-29 | -$2.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $116.00K 10-Q · filed 2025-07-31 | -$2.26M derived: sum of 3 quarters · filed 2026-02-26 | -$1.51M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$7.00K 10-Q · filed 2025-05-01 | -$2.38M derived: sum of 2 quarters · filed 2026-02-26 | -$1.63M derived: sum of 3 quarters · filed 2026-02-26 | $1.05M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.63M derived: sum of 2 quarters · filed 2026-02-26 | $1.06M derived: sum of 3 quarters · filed 2026-02-26 | $288.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $751.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.44M derived: sum of 2 quarters · filed 2024-11-07 | $2.67M 10-Q · filed 2024-11-07 | $942.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.92M 10-Q · filed 2024-08-07 | $191.00K derived: sum of 3 quarters · filed 2025-03-03 | -$280.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$772.00K 10-Q · filed 2024-05-07 | -$2.50M derived: sum of 2 quarters · filed 2025-03-03 | -$2.97M derived: sum of 3 quarters · filed 2025-03-03 | -$2.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.19M derived: sum of 2 quarters · filed 2025-03-03 | -$1.42M derived: sum of 3 quarters · filed 2025-03-03 | -$1.94M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$471.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $300.00K derived: sum of 2 quarters · filed 2023-11-06 | -$211.00K 10-Q · filed 2023-11-06 | $544.00K derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $771.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $260.00K 10-Q · filed 2023-08-03 | $1.01M derived: sum of 3 quarters · filed 2024-03-01 | $1.39M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | -$511.00K 10-Q · filed 2023-05-03 | $244.00K derived: sum of 2 quarters · filed 2024-03-01 | $617.00K derived: sum of 3 quarters · filed 2024-03-01 | $484.00K derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $1.13M derived: sum of 2 quarters · filed 2024-03-01 | $995.00K derived: sum of 3 quarters · filed 2024-03-01 | -$260.00K 10-K · filed 2024-03-01 |
| 2021-09-30 | $373.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $240.00K derived: sum of 2 quarters · filed 2022-11-08 | -$1.01M 10-Q · filed 2022-11-08 | -$838.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.39M 10-Q · filed 2022-08-04 | -$1.21M derived: sum of 3 quarters · filed 2023-02-27 | -$1.00M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$1.25M 10-Q · filed 2022-05-09 | -$1.08M derived: sum of 2 quarters · filed 2023-02-27 | -$869.00K derived: sum of 3 quarters · filed 2023-02-27 | -$748.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $386.00K derived: sum of 2 quarters · filed 2023-02-27 | $507.00K derived: sum of 3 quarters · filed 2023-02-27 | $447.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $330.00K derived: sum of 2 quarters · filed 2021-10-28 | $270.00K 10-Q · filed 2021-10-28 | $101.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $61.00K 10-Q · filed 2021-07-29 | -$108.00K derived: sum of 3 quarters · filed 2022-03-01 | -$212.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$60.00K 10-Q · filed 2021-04-28 | -$229.00K derived: sum of 2 quarters · filed 2022-03-01 | -$333.00K derived: sum of 3 quarters · filed 2022-03-01 | -$712.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$273.00K derived: sum of 2 quarters · filed 2022-03-01 | -$652.00K derived: sum of 3 quarters · filed 2022-03-01 | -$409.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$483.00K derived: sum of 2 quarters · filed 2020-10-29 | -$240.00K 10-Q · filed 2020-10-29 | -$4.80M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | -$379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$136.00K 10-Q · filed 2020-07-31 | -$4.70M derived: sum of 3 quarters · filed 2021-02-18 | -$213.00K derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $243.00K 10-Q · filed 2020-05-06 | -$4.32M derived: sum of 2 quarters · filed 2021-02-18 | $166.00K derived: sum of 3 quarters · filed 2021-02-18 | $181.00K derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | -$4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$77.00K derived: sum of 2 quarters · filed 2021-02-18 | -$62.00K derived: sum of 3 quarters · filed 2021-02-18 | $69.00K 10-K · filed 2021-02-18 |
| 2018-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.50M derived: sum of 2 quarters · filed 2019-11-05 | $4.63M 10-Q · filed 2019-11-05 | $6.56M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $146.00K 10-Q · filed 2019-08-07 | $2.07M derived: sum of 3 quarters · filed 2020-03-02 | $2.26M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $131.00K 10-Q · filed 2019-05-08 | $2.05M derived: sum of 2 quarters · filed 2020-03-02 | $2.25M derived: sum of 3 quarters · filed 2020-03-02 | $2.27M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.12M derived: sum of 2 quarters · filed 2020-03-02 | $2.14M derived: sum of 3 quarters · filed 2020-03-02 | $2.37M 10-K · filed 2020-03-02 |
| 2017-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $214.00K derived: sum of 2 quarters · filed 2018-11-09 | $449.00K 10-Q · filed 2018-11-09 | $1.95M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $254.00K 10-Q · filed 2018-08-07 | $1.75M derived: sum of 3 quarters · filed 2019-03-01 | $2.88M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $235.00K 10-Q · filed 2018-05-08 | $1.73M derived: sum of 2 quarters · filed 2019-03-01 | $2.87M derived: sum of 3 quarters · filed 2019-03-01 | $3.58M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.63M derived: sum of 2 quarters · filed 2019-03-01 | $3.35M derived: sum of 3 quarters · filed 2019-03-01 | $1.90M 10-K · filed 2019-03-01 |
| 2016-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.85M derived: sum of 2 quarters · filed 2017-11-08 | $402.00K 10-Q · filed 2017-11-08 | $1.97M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$732.00K 10-Q · filed 2017-08-08 | $835.00K derived: sum of 3 quarters · filed 2019-01-29 | -$939.00K derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | -$1.45M 10-Q · filed 2017-05-10 | $120.00K derived: sum of 2 quarters · filed 2019-01-29 | -$1.65M derived: sum of 3 quarters · filed 2019-01-29 | -$1.65M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $1.57M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | -$207.00K derived: sum of 2 quarters · filed 2019-01-29 | -$204.00K derived: sum of 3 quarters · filed 2019-01-29 | $305.00K 8-K · filed 2019-01-29 |
| 2015-09-30 | -$1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$1.77M derived: sum of 2 quarters · filed 2016-11-07 | -$1.26M 10-Q · filed 2016-11-07 | $6.58M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $512.00K 10-Q · filed 2016-08-08 | $8.36M derived: sum of 3 quarters · filed 2017-03-01 | $7.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $509.00K 10-Q · filed 2016-05-09 | $8.35M derived: sum of 2 quarters · filed 2017-03-01 | $7.80M derived: sum of 3 quarters · filed 2017-03-01 | $5.32M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $7.29M derived: sum of 2 quarters · filed 2017-03-01 | $4.81M derived: sum of 3 quarters · filed 2017-03-01 | $3.38M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$3.04M derived: sum of 2 quarters · filed 2015-11-09 | -$4.46M 10-Q · filed 2015-11-09 | -$3.40M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$3.91M 10-Q · filed 2015-08-05 | -$2.84M derived: sum of 3 quarters · filed 2016-02-29 | -$3.27M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$1.43M 10-Q · filed 2015-05-11 | -$360.00K derived: sum of 2 quarters · filed 2016-02-29 | -$788.00K derived: sum of 3 quarters · filed 2016-02-29 | -$814.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $641.00K derived: sum of 2 quarters · filed 2016-02-29 | $615.00K derived: sum of 3 quarters · filed 2016-02-29 | $544.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$454.00K derived: sum of 2 quarters · filed 2014-11-07 | -$525.00K 10-Q · filed 2014-11-07 | -$87.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$97.00K 10-Q · filed 2014-08-11 | $341.00K derived: sum of 3 quarters · filed 2015-02-27 | $275.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$71.00K 10-Q · filed 2014-05-09 | $367.00K derived: sum of 2 quarters · filed 2015-02-27 | $301.00K derived: sum of 3 quarters · filed 2015-02-27 | $297.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $372.00K derived: sum of 2 quarters · filed 2015-02-27 | $368.00K derived: sum of 3 quarters · filed 2015-02-27 | $361.00K 10-K · filed 2015-02-27 |
| 2012-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$70.00K derived: sum of 2 quarters · filed 2013-11-12 | -$77.00K 10-Q · filed 2013-11-12 | -$40.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$11.00K 10-Q · filed 2013-08-09 | $26.00K derived: sum of 3 quarters · filed 2014-03-03 | -$9.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$7.00K 10-Q · filed 2013-05-10 | $30.00K derived: sum of 2 quarters · filed 2014-03-03 | -$5.00K derived: sum of 3 quarters · filed 2014-03-03 | $57.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $2.00K derived: sum of 2 quarters · filed 2014-03-03 | $64.00K derived: sum of 3 quarters · filed 2014-03-03 | -$16.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $27.00K derived: sum of 2 quarters · filed 2012-11-09 | -$53.00K 10-Q · filed 2012-11-09 | -$48.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$18.00K 10-Q · filed 2012-08-09 | -$13.00K derived: sum of 3 quarters · filed 2013-03-18 | $74.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$80.00K 10-Q · filed 2012-05-10 | -$75.00K derived: sum of 2 quarters · filed 2013-03-18 | $12.00K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $92.00K derived: sum of 2 quarters · filed 2013-03-18 | -$13.00K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$18.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$105.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $58.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |